Prieto-Pena, D.Bernabeu, P.Vela-Casasempere, P.Narvaez, J.Fernandez-Lopez, C.Freire Gonzalez, M.Gonzalez-Alvarez, B.Solans-Laque, R.Callejas-Rubio, J. L.Ortego, N.Fernandez-Diaz, C.Rubio Romero, E.Garcia Morillo, S.Minguez, M.Fernandez-Carballido, C.De Miguel, E.Melchor, S.Salgado-Perez, E.Bravo, B.Romero-Yuste, S.Salvatierra, J.Hidalgo, C.Manrique Arija, S.Romero-Gomez, C.Moya, P.Alvarez-Rivas, N.Mendizabal, J.Ortiz Sanjuan, F. M.Perez de Pedro, I.Alonso Valdivieso, J. L.Laura, P. S.Rosa, R. M.Fernandez-Llanio, N.Gomez de la Torre, R.Suarez, S.Montesa, M. J.Delgado Sanchez, M.Loricera, J.Atienza-Mateo, B.Castaneda, S.Gonzalez-Gay, M. A.Blanco, R.2025-01-072025-01-072021-06-010003-4967https://hdl.handle.net/10668/25907enTOCILIZUMAB FOR TAKAYASU ARTERITIS: MULTICENTER STUDY OF 54 WHITE PATIENTSconference outputopen access10.1136/annrheumdis-2021-eular.17471468-2060https://ard.bmj.com/content/annrheumdis/80/Suppl_1/1208.2.full.pdf692625300366